Based on the existing data showing the aberrantly low expression of the CEBPA gene in patients with acute leukemia harboring the CALM/AF10 fusion gene, we decided to evaluate in vivo if haploinsufficiency of CEBPA predisposes CALM/AF10+ hematopoietic cells to develop leukemia. This evidence concerns the gene MLLT10 and leukemia.